Measuring Diabetic Neuropathy: Assessment and Comparison of Clinical Examination and Quantitative Sensory Testing Diabetes Care April 1989 12:270-275; doi:10.2337/diacare.12.4.270
Measuring Diabetic Neuropathy: Assessment and Comparison of Clinical Examination and Quantitative Sensory Testing Diabetes Care April 1989 12:270-275; doi:10.2337/diacare.12.4.270
Elevated Plasma Glucose and Lowered Triglyceride Levels From Omega-3 Fatty Acid Supplementation in Type II Diabetes Diabetes Care April 1989 12:276-281; doi:10.2337/diacare.12.4.276
Ultrasonic Measurement of Forearm Subcutaneous Adipose Tissue Thickness Suitable for Monitoring of Subcutaneous Glucose Concentration?
Diabetes Care April 1989 12:305-306; doi:10.2337/diacare.12.4.305
Braione, Antonia F
Hyperglycemic Effect of Sucrose Ingestion in IDDM Patients Controlled by Artificial Pancreas Diabetes Care April 1989 12:296-298; doi:10.2337/diacare.12.4.296
Elevated Plasma Glucose and Lowered Triglyceride Levels From Omega-3 Fatty Acid Supplementation in Type II Diabetes Diabetes Care April 1989 12:276-281; doi:10.2337/diacare.12.4.276
Hyperglycemic Effect of Sucrose Ingestion in IDDM Patients Controlled by Artificial Pancreas Diabetes Care April 1989 12:296-298; doi:10.2337/diacare.12.4.296
Importance of Cardiovascular Autonomic Dysfunction in IDDM Subjects With Diabetic Nephropathy Diabetes Care April 1989 12:259-264; doi:10.2337/diacare.12.4.259
Improved Insulin Response and Action by Chronic Magnesium Administration in Aged NIDDM Subjects Diabetes Care April 1989 12:265-269; doi:10.2337/diacare.12.4.265
Measuring Diabetic Neuropathy: Assessment and Comparison of Clinical Examination and Quantitative Sensory Testing Diabetes Care April 1989 12:270-275; doi:10.2337/diacare.12.4.270
Elevated Plasma Glucose and Lowered Triglyceride Levels From Omega-3 Fatty Acid Supplementation in Type II Diabetes Diabetes Care April 1989 12:276-281; doi:10.2337/diacare.12.4.276
Hyperglycemic Effect of Sucrose Ingestion in IDDM Patients Controlled by Artificial Pancreas Diabetes Care April 1989 12:296-298; doi:10.2337/diacare.12.4.296
Ultrasonic Measurement of Forearm Subcutaneous Adipose Tissue Thickness Suitable for Monitoring of Subcutaneous Glucose Concentration?
Diabetes Care April 1989 12:305-306; doi:10.2337/diacare.12.4.305
Friday, Karen E
Elevated Plasma Glucose and Lowered Triglyceride Levels From Omega-3 Fatty Acid Supplementation in Type II Diabetes Diabetes Care April 1989 12:276-281; doi:10.2337/diacare.12.4.276
Elevated Plasma Glucose and Lowered Triglyceride Levels From Omega-3 Fatty Acid Supplementation in Type II Diabetes Diabetes Care April 1989 12:276-281; doi:10.2337/diacare.12.4.276
Hyperglycemic Effect of Sucrose Ingestion in IDDM Patients Controlled by Artificial Pancreas Diabetes Care April 1989 12:296-298; doi:10.2337/diacare.12.4.296
Hyperglycemic Effect of Sucrose Ingestion in IDDM Patients Controlled by Artificial Pancreas Diabetes Care April 1989 12:296-298; doi:10.2337/diacare.12.4.296
Importance of Cardiovascular Autonomic Dysfunction in IDDM Subjects With Diabetic Nephropathy Diabetes Care April 1989 12:259-264; doi:10.2337/diacare.12.4.259
Importance of Cardiovascular Autonomic Dysfunction in IDDM Subjects With Diabetic Nephropathy Diabetes Care April 1989 12:259-264; doi:10.2337/diacare.12.4.259
Measuring Diabetic Neuropathy: Assessment and Comparison of Clinical Examination and Quantitative Sensory Testing Diabetes Care April 1989 12:270-275; doi:10.2337/diacare.12.4.270
Measuring Diabetic Neuropathy: Assessment and Comparison of Clinical Examination and Quantitative Sensory Testing Diabetes Care April 1989 12:270-275; doi:10.2337/diacare.12.4.270
Measuring Diabetic Neuropathy: Assessment and Comparison of Clinical Examination and Quantitative Sensory Testing Diabetes Care April 1989 12:270-275; doi:10.2337/diacare.12.4.270
Measuring Diabetic Neuropathy: Assessment and Comparison of Clinical Examination and Quantitative Sensory Testing Diabetes Care April 1989 12:270-275; doi:10.2337/diacare.12.4.270
Measuring Diabetic Neuropathy: Assessment and Comparison of Clinical Examination and Quantitative Sensory Testing Diabetes Care April 1989 12:270-275; doi:10.2337/diacare.12.4.270
Improved Insulin Response and Action by Chronic Magnesium Administration in Aged NIDDM Subjects Diabetes Care April 1989 12:265-269; doi:10.2337/diacare.12.4.265
Improved Insulin Response and Action by Chronic Magnesium Administration in Aged NIDDM Subjects Diabetes Care April 1989 12:265-269; doi:10.2337/diacare.12.4.265
Improved Insulin Response and Action by Chronic Magnesium Administration in Aged NIDDM Subjects Diabetes Care April 1989 12:265-269; doi:10.2337/diacare.12.4.265
Hyperglycemic Effect of Sucrose Ingestion in IDDM Patients Controlled by Artificial Pancreas Diabetes Care April 1989 12:296-298; doi:10.2337/diacare.12.4.296
Importance of Cardiovascular Autonomic Dysfunction in IDDM Subjects With Diabetic Nephropathy Diabetes Care April 1989 12:259-264; doi:10.2337/diacare.12.4.259
Improved Insulin Response and Action by Chronic Magnesium Administration in Aged NIDDM Subjects Diabetes Care April 1989 12:265-269; doi:10.2337/diacare.12.4.265
Elevated Plasma Glucose and Lowered Triglyceride Levels From Omega-3 Fatty Acid Supplementation in Type II Diabetes Diabetes Care April 1989 12:276-281; doi:10.2337/diacare.12.4.276
Hyperglycemic Effect of Sucrose Ingestion in IDDM Patients Controlled by Artificial Pancreas Diabetes Care April 1989 12:296-298; doi:10.2337/diacare.12.4.296
Improved Insulin Response and Action by Chronic Magnesium Administration in Aged NIDDM Subjects Diabetes Care April 1989 12:265-269; doi:10.2337/diacare.12.4.265
Importance of Cardiovascular Autonomic Dysfunction in IDDM Subjects With Diabetic Nephropathy Diabetes Care April 1989 12:259-264; doi:10.2337/diacare.12.4.259
Importance of Cardiovascular Autonomic Dysfunction in IDDM Subjects With Diabetic Nephropathy Diabetes Care April 1989 12:259-264; doi:10.2337/diacare.12.4.259